Home
Menu
Updates
ARISTO has registered highest growth rate (14.55%) among top 12 pharmaceutical companies in India (Source-IMS MAT April 2017)ARISTO is ranked No. 3 in its covered market (Source-IMS MAT April 2017)ARISTO continues to be among the top 10 companies of India as per SMSRC prescription auditARISTO has introduced India’s 1st ready-to-use, multi-dose probiotic formulation ‘Darolac Syrup’ in association with Royal Holloway University of LondonARISTO has launched ready-to-drink, WHO recommended ORS formula ‘Olyte ORS’.ARISTO has entered anticoagulant segment with the launch of ‘Fondum’ PFS
Archive

ARISTO has registered highest growth rate (14.55%) among top 12 pharmaceutical companies in India (Source-IMS MAT April 2017)

Posted: June 19, 2017 at 9:22 am   /   Featured

No Comments read more

ARISTO is ranked No. 3 in its covered market (Source-IMS MAT April 2017)

Posted: June 19, 2017 at 9:20 am   /   Featured

No Comments read more

ARISTO continues to be among the top 10 companies of India as per SMSRC prescription audit

Posted: June 19, 2017 at 9:19 am   /   Uncategorized

No Comments read more

ARISTO has introduced India’s 1st ready-to-use, multi-dose probiotic formulation ‘Darolac Syrup’ in association with Royal Holloway University of London

Posted: June 19, 2017 at 9:18 am   /   Uncategorized

No Comments read more

ARISTO has launched ready-to-drink, WHO recommended ORS formula ‘Olyte ORS’.

Posted: June 19, 2017 at 9:17 am   /   Featured

No Comments read more

ARISTO has entered anticoagulant segment with the launch of ‘Fondum’ PFS

Posted: June 19, 2017 at 9:16 am   /   Featured

No Comments read more
© ARISTO Pharmaceuticals Private Limited
error: Content is protected !!